Skip to main content
. 2020 Dec 8;16(11):1201–1216. doi: 10.1080/15592294.2020.1853402

Table 1.

Differentially methylated genes between different ovarian cancer groups and HOSE (FDR<0.05, |Δβ|>0.1)

  Numbers of Genes
Hypermethylated Hypomethylated
Primary OC vs. HOSE 1810 837
Recurrent OC vs. HOSE 1541 1101
Guadecitabine-treated OC vs. HOSE 1364 870